SSA
PAVM icon

Schonfeld Strategic Advisors’s PAVmed PAVM Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-209
Closed -$88K – 3112
2022
Q2 		$88K Sell
209
-25
-11% -$12.1K ﹤0.01% 2167
2022
Q1 		$139K Buy
+234
New +$174K ﹤0.01% 2129
2021
Q2 		– Sell
-122
Closed -$245K – 2204
2021
Q1 		$245K Buy
122
+87
+249% +$131K ﹤0.01% 1423
2020
Q4 		$33K Buy
+35
New +$29.9K ﹤0.01% 1513

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Schonfeld Strategic Advisors's PAVM Position: Q3 2022 in Review

Schonfeld Strategic Advisors sold out of PAVmed (PAVM) in Q3 2022, closing a stake of 209 shares — an estimated $88K sold.

Schonfeld Strategic Advisors first reported a position in PAVM in Q4 2020 and held it in 4 quarters. The position peaked at $245K in Q1 2021. 70 funds tracked by Wall St. Rank hold PAVM as of Q3 2022.

  • Schonfeld Strategic Advisors reported no remaining PAVmed position as of Q3 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 209 PAVmed shares in Q3 2022, an estimated $88K.
  • Schonfeld Strategic Advisors first reported a position in PAVmed in Q4 2020 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's PAVmed position peaked at $245K in Q1 2021.
  • 70 funds tracked by Wall St. Rank held PAVmed as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.